The Berlin School of Integrative Oncology (BSIO) is a joint graduate school of the Charité, HU, FU and non-university research institutions.

BSIO, which is funded under the Excellence Initiative by the German Federal Ministry of Education and Research, offers an interdisciplinary program. Researchers in Haematology, Oncology, Genetics, Biochemistry, Surgery, Radiology, Computer Science as well as Social Studies and the Humanities collaborate closely at BSIO to train tomorrow’s molecular oncologists and physicians. BSIO is a member of Dahlem Research School.

Cancer is one of the major challenges facing medicine and society. Fighting this disease is the focus of work at BSIO. Its mission is to understand the individual molecular blueprint of a tumor and develop customized therapy plans for patients. Such “personalized cancer medicine” is one of the graduate school’s core areas.

BSIO features a comprehensive curriculum as well as excellent research opportunities and creates substantive dialogue between bio-scientific research and clinical application, aiming to expedite the development of therapies. At the same time, experimental lab research receives important input, driving it to give the highest priority to urgent problems of clinical cancer therapy. Open to excellent M.Sc. (and B.Sc.) graduates in natural sciences as well as medical students and graduates, BSIO offers a structured three-year doctoral program including opportunities for international lab rotations, thus educating a new generation of cancer researchers.

Humboldt-Universität zu Berlin Freie Universität Berlin programme dialog Prof. Dr Clemens A. Schmitt Eleanor Horn 

Berlin School of Integrative Oncology, BSIO, Cancer